Cytoplasmic SIRT6-mediated ACSL5 deacetylation impedes nonalcoholic fatty liver disease by facilitating hepatic fatty acid oxidation.
Hou T, Tian Y, Cao Z, Zhang J, Feng T, Tao W, Sun H, Wen H, Lu X, Zhu Q, Li M, Lu X, Liu B, Zhao Y, Yang Y, Zhu WG.
Hou T, et al. Among authors: tao w.
Mol Cell. 2022 Nov 3;82(21):4099-4115.e9. doi: 10.1016/j.molcel.2022.09.018. Epub 2022 Oct 7.
Mol Cell. 2022.
PMID: 36208627
Free article.